Environmental Risk Assessment for rVSVΔG-ZEBOV-GP, a Genetically Modified Live Vaccine for Ebola Virus Disease

rVSVΔG-ZEBOV-GP is a live, attenuated, recombinant vesicular stomatitis virus (rVSV)-based vaccine for the prevention of Ebola virus disease caused by <i>Zaire ebolavirus</i>. As a replication-competent genetically modified organism, rVSVΔG-ZEBOV-GP underwent various environmental evaluations prior...

Description complète

Détails bibliographiques

Auteurs principaux:	Joan G. Tell, Beth-Ann G. Coller, Sheri A. Dubey, Ursula Jenal, William Lapps, Liman Wang, Jayanthi Wolf
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2020-12-01
Collection:	Vaccines
Sujets:	ERA rVSV recombinant vaccine GMO vesicular stomatitis virus <i>Zaire ebolavirus</i>
Accès en ligne:	https://www.mdpi.com/2076-393X/8/4/779
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!